SARS-CoV-2 Antigen Rapid Qualitative Test Type B

SARS-CoV-2 Antigen Rapid Qualitative Test Type A

FT3 Rapid Quantitative Test (Chemiluminescence Immunoassay)

FT3 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Free triiodothyronine 3 (FT3) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.

NT-proBNP Rapid Quantitative Test

NT-proBNP is a marker for detecting heart function, with a long half-life and high specificity. Biotime NT-proBNP test kit detects the amount of NT-proBNP in human whole blood, serum and plasma samples.

MAU Rapid Quantitative Test

MAU(Microalbumin) occurs when the kidney leaks small amounts of albumin into the urine, which is an early marker of kidney damage.

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay)

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the D-Dimer concentration in human sodium citrate anticoagulant-contained plasma (1:9) and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

HLC-100 Fully Automated HbA1c Analyzer

Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.

CK-MB Rapid Quantitative Test (Chemiluminescence Immunoassay)

CK-MB Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Creatine kinase-MB (CK-MB) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type B